U.S. to see surge in new obesity drug launches in next five years
Encouraged by the performance of Wegovy and Mounjaro, companies are racing to commercialize their alternative obesity treatments, as a prodigious 13 drug launches are projected over the next five years in the United States, according to GlobalData.